Award
NIH Reporter #5R01AI173138-04
Clinical Impact of the Cefazolin Inoculum Effect
Recipient
Methodist Hospital Research Institute, Houston, TX, United States
Award Amount
$425,805.00
Ceiling
$425,805.00
Awarded
August 14, 2026
Identifier
5R01AI173138-04
A research grant awarded to study the clinical impact of the cefazolin inoculum effect on MSSA bacteremia and to validate a rapid diagnostic tool internationally to improve treatment outcomes.
Description
This NIH grant project focuses on assessing the clinical impact of the cefazolin inoculum effect (CzIE) on methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia outcomes and validating a rapid diagnostic assay across international sites to optimize antibiotic use and improve patient outcomes.